Nadia Baillargeon

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Patient Reported Outcomes

Gene Expression

Cardiac Surgery

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Maude Cigna, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Nancy Robitaille
Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation. Transfusion 64 (3) (2024)
Maude Cigna, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Nancy Robitaille
Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation. Transfusion 64 (3) (2024)
Maude Cigna, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Nancy Robitaille
Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation. Transfusion (2024)
Gabriel André Leiva-Torres, Marie-Claire Chevrier, Jessica Constanzo-Yanez, Antoine Lewin, Josée Lavoie, Josée Laganière, Nadia Baillargeon, Patrick Trépanier, Nancy Robitaille
High prevalence of weak D type 42 in a large-scale RHD genotyping program in the province of Quebec (Canada). Transfusion 61 (9) (2021)
Gabriel André Leiva-Torres, Josée Lavoie, Carole Ethier, Jessica Constanzo-Yanez, Nadia Baillargeon
A novel KEL null allele with c.223+1g>t leads to the absence of the Kpb antigen in a First Nation donor. Transfusion 61 (9) (2021)
Pierre-Aurèle Morin, Carole Ethier, Josée Lavoie, Nancy Robitaille, Nadia Baillargeon
A novel variant DO*A allele with a c.370delT mutation leading to a DO-null phenotype in a Syrian family. Transfusion 61 (2) (2020)